Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Bexell

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
The Journal of Pathology|September 25, 2018
The Iroquois homeobox proteins IRX3 and IRX5 have distinct roles in Wilms tumour development and human nephrogenesisLinda Holmquist Mengelbier, Simon Lindell-Munther, Hiroaki Yasui, et al.
Science Translational Medicine|September 24, 2020
Therapeutic targeting of KSP in preclinical models of high-risk neuroblastomaKarin Hansson, Katarzyna Radke, Kristina Aaltonen, et al.
International Journal of Molecular Sciences|September 11, 2020
Discovery of <i>epi</i>-Enprioline as a Novel Drug for the Treatment of Vincristine Resistant NeuroblastomaWondossen Sime, Mohamed Jemaà, Yasmin Abassi, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 2, 2009
Immunizations with IFNgamma secreting tumor cells can eliminate fully established and invasive rat gliomasShorena Janelidze, Daniel Bexell, Wiaam Badn, et al.
EMBO Molecular Medicine|January 10, 2020
Anti-tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL-302 in neuroblastomaSofie Mohlin, Karin Hansson, Katarzyna Radke, et al.
EMBO Molecular Medicine|July 17, 2019
Anti-tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL-302 in neuroblastomaSofie Mohlin, Karin Hansson, Katarzyna Radke, et al.
NPJ Precision Oncology|September 16, 2025
Targeted ferroptosis induction enhances chemotherapy efficacy in chemoresistant neuroblastomaAdriana Mañas, Alexandra Seger, Aleksandra Adamska, et al.
Pediatric Blood & Cancer|June 25, 2025
Evaluation of TRPA1 as a Therapeutic Target in MYCN-Amplified NeuroblastomaAlexandra Seger, Dora Adamič, Erick Muciño Olmos, et al.
Nature Communications|October 12, 2016
Cancer-associated fibroblast-secreted CXCL16 attracts monocytes to promote stroma activation in triple-negative breast cancersRoni Allaoui, Caroline Bergenfelz, Sofie Mohlin, et al.
International Journal of Cancer|September 16, 2014
Neuroblastoma patient-derived orthotopic xenografts retain metastatic patterns and geno- and phenotypes of patient tumoursNoémie Braekeveldt, Caroline Wigerup, David Gisselsson, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
The Journal of Pathology|September 25, 2018
The Iroquois homeobox proteins IRX3 and IRX5 have distinct roles in Wilms tumour development and human nephrogenesisLinda Holmquist Mengelbier, Simon Lindell-Munther, Hiroaki Yasui, et al.
Science Translational Medicine|September 24, 2020
Therapeutic targeting of KSP in preclinical models of high-risk neuroblastomaKarin Hansson, Katarzyna Radke, Kristina Aaltonen, et al.
International Journal of Molecular Sciences|September 11, 2020
Discovery of <i>epi</i>-Enprioline as a Novel Drug for the Treatment of Vincristine Resistant NeuroblastomaWondossen Sime, Mohamed Jemaà, Yasmin Abassi, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 2, 2009
Immunizations with IFNgamma secreting tumor cells can eliminate fully established and invasive rat gliomasShorena Janelidze, Daniel Bexell, Wiaam Badn, et al.
EMBO Molecular Medicine|January 10, 2020
Anti-tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL-302 in neuroblastomaSofie Mohlin, Karin Hansson, Katarzyna Radke, et al.
EMBO Molecular Medicine|July 17, 2019
Anti-tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL-302 in neuroblastomaSofie Mohlin, Karin Hansson, Katarzyna Radke, et al.
NPJ Precision Oncology|September 16, 2025
Targeted ferroptosis induction enhances chemotherapy efficacy in chemoresistant neuroblastomaAdriana Mañas, Alexandra Seger, Aleksandra Adamska, et al.
Pediatric Blood & Cancer|June 25, 2025
Evaluation of TRPA1 as a Therapeutic Target in MYCN-Amplified NeuroblastomaAlexandra Seger, Dora Adamič, Erick Muciño Olmos, et al.
Nature Communications|October 12, 2016
Cancer-associated fibroblast-secreted CXCL16 attracts monocytes to promote stroma activation in triple-negative breast cancersRoni Allaoui, Caroline Bergenfelz, Sofie Mohlin, et al.
International Journal of Cancer|September 16, 2014
Neuroblastoma patient-derived orthotopic xenografts retain metastatic patterns and geno- and phenotypes of patient tumoursNoémie Braekeveldt, Caroline Wigerup, David Gisselsson, et al.
Pageof 5